Maher Awad
Psychiatry · Aberdeen, NJNPI 1134106677
Payments from drug & device makers
Across 409 payments — averaging $22.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Sunovion Pharmaceuticals Inc.$909
- Johnson & Johnson$499
- Alkermes, Inc.$463
- Otsuka America Pharmaceutical, Inc.$359
- plus $777 from 9 others
What the payments were for
- Food & beverage$9,235100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 279 | $4,228 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $2,009 |
| Sunovion Pharmaceuticals Inc. | 32 | $909 |
| Johnson & Johnson | 20 | $499 |
| Alkermes, Inc. | 10 | $463 |
| Otsuka America Pharmaceutical, Inc. | 8 | $359 |
| Teva Pharmaceuticals USA, Inc. | 10 | $311 |
| Sanofi | 1 | $123 |
| Avanir Pharmaceuticals, Inc. | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Lundbeck LLC | 4 | $56 |
| Indivior Inc. | 3 | $50 |
| Shire North American Group Inc | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$1,466
- VRAYLAR$1,188
- ARISTADA$852
- LATUDA$349
- INVEGA SUSTENNA$254
- ARISTADA INITIO$213
- KEVZARA$123
- UZEDY$120
- ABILIFY MAINTENA$120
- ABILIFY ASIMTUFII$120
- REXULTI$112
- NUEDEXTA$107
How this compares
$9,244 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Varenicline Tartrate | 12 | $2,540 |
| Buprenorphine Hcl | 52 | $1,706 |
| Clozapine | 12 | $1,063 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $854 |
| Duloxetine Hcl | 62 | $674 |
| Bupropion XlBupropion Hcl | 53 | $672 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $291 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $290 |
| Alprazolam | 56 | $281 |
| Sertraline Hcl | 46 | $269 |
| Escitalopram Oxalate | 33 | $255 |
| Clonazepam | 70 | $244 |
| Fluoxetine Hcl | 11 | $241 |
| Gabapentin | 26 | $198 |
| Trazodone Hcl | 49 | $178 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Aberdeen
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.